arrow
W

William McCoull

chemistry
H指数:24
被引数:2,115

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

AZ14289671 is a highly selective and blood-brain barrier penetrant irreversible TKI that targets EGFRExon20 insertions

AZ14289671 是一种高选择性的血脑屏障穿透性不可逆TKI,可靶向EGFRExon20插入突变。

2025-08-250
OAAI
Highly Optimized CNS Penetrant Inhibitors of EGFR Exon20 Insertion Mutations

高度优化的中枢神经系统穿透性EGFR外显子20插入突变抑制剂

2025-01-271
PRE
Optimization of Potent, Efficacious, Selective and Blood-Brain Barrier Penetrating Inhibitors Targeting EGFR Exon20 Insertion Mutations
2024-09-280
PRE
Discovery and Optimization of Potent, Efficacious and Selective Inhibitors Targeting EGFR Exon20 Insertion Mutations
2024-05-212
PRE
Optimization of an Imidazo[1,2-a]pyridine Series to Afford Highly Selective Type I1/2 Dual Mer/Axl Kinase Inhibitors with In Vivo Efficacy
2021-09-0319
PRE
Generating Selective Leads for Mer Kinase Inhibitors-Example of a Comprehensive Lead-Generation Strategy
2021-03-0818
PREAI
Design and optimisation of dendrimer-conjugated Bcl-2/xL inhibitor, AZD0466, with improved therapeutic index for cancer therapy
2021-01-2567
OAAI
Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6
2018-10-17120
OAAI
Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic Inhibitors (vol 60, pg 4386, 2017)
2017-07-171
OAAI
Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic Inhibitors
2017-05-0964
OAAI
Indazole-6-phenylcyclopropylcarboxylic Acids as Selective GPR120 Agonists with in Vivo Efficacy
2017-04-0431
PREAI
Identification, Optimization, and Pharmacology of Acylurea GHS-R1a Inverse Agonists
2014-07-0829
PREAI